{"name":"Prof JMA Lange","slug":"prof-jma-lange","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ART only arm","genericName":"ART only arm","slug":"art-only-arm","indication":"HIV-1 infection (standard antiretroviral therapy)","status":"marketed"},{"name":"Experimental: Empiric TB treatment","genericName":"Experimental: Empiric TB treatment","slug":"experimental-empiric-tb-treatment","indication":"Tuberculosis (pulmonary and extrapulmonary)","status":"marketed"}]}],"pipeline":[{"name":"ART only arm","genericName":"ART only arm","slug":"art-only-arm","phase":"marketed","mechanism":"ART (antiretroviral therapy) only arm refers to HIV treatment using combination antiretroviral drugs without additional interventions.","indications":["HIV-1 infection (standard antiretroviral therapy)"],"catalyst":""},{"name":"Experimental: Empiric TB treatment","genericName":"Experimental: Empiric TB treatment","slug":"experimental-empiric-tb-treatment","phase":"marketed","mechanism":"Empiric TB treatment is a combination regimen of multiple anti-tuberculous agents designed to target Mycobacterium tuberculosis through different mechanisms to prevent drug resistance.","indications":["Tuberculosis (pulmonary and extrapulmonary)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}